Strategies for Development of Next-Gen AAVs
Source: Cytiva
In this video, Douglas Sanders, Ph.D., VP Head of Translational Medicine at AVROBIO details why the field is now recognizing that natural naturally occurring AAVs have both strengths and drawbacks. Sanders explains the strengths and drawbacks and why now is an exciting and important time in AAV biology.
access the Virtual Event!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more